Literature DB >> 17128405

Modulation of apelin and APJ receptor in normal and preeclampsia-complicated placentas.

L Cobellis1, M De Falco, A Mastrogiacomo, D Giraldi, D Dattilo, C Scaffa, N Colacurci, A De Luca.   

Abstract

Apelin is an endogenous ligand of the human orphan receptor APJ. This peptide is produced through processing from the C-terminal portion in the pre-pro-protein consisting of 77 amino acid residues and exists in multiple molecular forms. Although the main physiological functions of apelin have not yet been clarified, it is known that apelin is involved in the regulation of blood pressure, blood flow and central control of body fluid homeostasis in different organs. Since human placenta is a tissue where vasculogenesis, blood pressure and flow are dramatically important to allow a normal embryonic and fetal growth and development, the aim of the present study was to investigate the immunohistochemical distribution of apelin and APJ in normal placentas throughout pregnancy and in preeclampsia-complicated placentas. Specifically, we observed that in normal placentas the expression levels of apelin decreased from the first to the third trimester of gestation in both cytotrophoblast and syncytiotrophoblast cells and in the stroma of placental villi, in contrast with increased expression levels of APJ in the cytoplasm of cytotrophoblast cells and in the cytoplasm of endothelial cells of normal placenta samples. In contrast, in preeclampsia-complicated pregnancies, we observed a very strong increase of expression levels of both apelin and APJ receptor in all the placental compartments, cytotrophoblast, syncytiotrophoblast and stroma with a particular increase in endothelial cells inside preeclamptic placental villi. Our data seem to indicate an important role of apelin and APJ in the regulation of fetal development through a correct regulation of human placenta formation during pregnancy. Moreover, the strong expression levels of apelin and APJ in preeclamptic placentas, suggest their possible involvement in the onset of this pathology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17128405     DOI: 10.14670/HH-22.1

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  17 in total

Review 1.  The apelinergic system: a perspective on challenges and opportunities in cardiovascular and metabolic disorders.

Authors:  Eric Marsault; Catherine Llorens-Cortes; Xavier Iturrioz; Hyung J Chun; Olivier Lesur; Gavin Y Oudit; Mannix Auger-Messier
Journal:  Ann N Y Acad Sci       Date:  2019-06-25       Impact factor: 5.691

2.  Apelin is a novel regulator of human trophoblast amino acid transport.

Authors:  O R Vaughan; T L Powell; T Jansson
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-03-05       Impact factor: 4.310

3.  Cord blood nesfatin-1 and apelin-36 levels in gestational diabetes mellitus.

Authors:  Mehmet Aslan; Onder Celik; Nilufer Celik; Ilgin Turkcuoglu; Ercan Yilmaz; Abdullah Karaer; Yavuz Simsek; Ebru Celik; Suleyman Aydin
Journal:  Endocrine       Date:  2011-12-28       Impact factor: 3.633

Review 4.  Regulation of the Apelinergic System and Its Potential in Cardiovascular Disease: Peptides and Small Molecules as Tools for Discovery.

Authors:  Sanju Narayanan; Danni L Harris; Rangan Maitra; Scott P Runyon
Journal:  J Med Chem       Date:  2015-07-10       Impact factor: 7.446

Review 5.  From apelin to exercise: emerging therapies for management of hypertension in pregnancy.

Authors:  Jeffrey S Gilbert
Journal:  Hypertens Res       Date:  2017-04-06       Impact factor: 3.872

6.  Apelin is decreased with human preterm and term labor and regulates prolabor mediators in human primary amnion cells.

Authors:  Ratana Lim; Gillian Barker; Clyde Riley; Martha Lappas
Journal:  Reprod Sci       Date:  2013-01-11       Impact factor: 3.060

7.  Downregulated Krüppel-like factor 8 is involved in decreased trophoblast invasion under hypoxia-reoxygenation conditions.

Authors:  Zhongmei Yang; Bing Bai; Xin Luo; Xiaoqiu Xiao; Xiru Liu; Yubin Ding; Hua Zhang; Li Gao; Juan Li; Hongbo Qi
Journal:  Reprod Sci       Date:  2013-05-23       Impact factor: 3.060

8.  ELABELA plasma concentrations are increased in women with late-onset preeclampsia.

Authors:  Bogdan Panaitescu; Roberto Romero; Nardhy Gomez-Lopez; Percy Pacora; Offer Erez; Felipe Vadillo-Ortega; Lami Yeo; Sonia S Hassan; Chaur-Dong Hsu
Journal:  J Matern Fetal Neonatal Med       Date:  2018-07-22

Review 9.  G-Protein-coupled receptors as potential drug candidates in preeclampsia: targeting the relaxin/insulin-like family peptide receptor 1 for treatment and prevention.

Authors:  Kirk P Conrad
Journal:  Hum Reprod Update       Date:  2016-07-06       Impact factor: 15.610

10.  Potential mechanisms of exercise in gestational diabetes.

Authors:  Saeid Golbidi; Ismail Laher
Journal:  J Nutr Metab       Date:  2013-04-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.